Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-12-22 Sale |
2022-12-27 9:00 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
175,225 | $25.93 | $4,543,514 | 20,310,554 (Indirect) |
View |
| 2022-12-20 Sale |
2022-12-22 9:00 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
215,756 | $25.84 | $5,575,585 | 20,485,779 (Indirect) |
View |
| 2022-12-08 Sale |
2022-12-09 3:43 pm |
Vir Biotechnology Inc. | VIR | SATO VICKI L Director |
17,915 | $25.81 | $462,366 | 1,381,089 (Direct) |
View |
| 2022-12-02 Sale |
2022-12-06 9:30 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
97,293 | $27.45 | $2,671,058 | 20,701,535 (Indirect) |
View |
| 2022-11-30 Sale |
2022-12-02 5:51 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
212,329 | $27.77 | $5,895,941 | 20,798,828 (Indirect) |
View |
| 2022-11-28 Sale |
2022-11-30 8:50 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
109,115 | $27.41 | $2,991,385 | 21,011,157 (Indirect) |
View |
| 2022-11-23 Sale |
2022-11-28 5:04 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
56,993 | $27.27 | $1,554,415 | 21,120,272 (Indirect) |
View |
| 2022-11-22 Sale |
2022-11-23 4:30 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
65,213 | $27.27 | $1,778,195 | 21,177,265 (Indirect) |
View |
| 2022-11-18 Sale |
2022-11-22 6:00 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
25,979 | $27.21 | $706,817 | 21,242,478 (Indirect) |
View |
| 2022-11-16 Sale |
2022-11-18 4:30 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
210,031 | $27.41 | $5,757,609 | 21,268,457 (Indirect) |
View |
| 2022-11-14 Sale |
2022-11-16 9:00 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
137,973 | $27.61 | $3,809,267 | 21,478,488 (Indirect) |
View |
| 2022-11-09 Sale |
2022-11-14 4:31 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
287,736 | $27.31 | $7,856,738 | 21,616,461 (Indirect) |
View |
| 2022-11-07 Sale |
2022-11-09 4:30 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
182,083 | $27.26 | $4,964,081 | 21,904,197 (Indirect) |
View |
| 2022-11-08 Sale |
2022-11-09 11:09 am |
Vir Biotechnology Inc. | VIR | SATO VICKI L Director |
17,915 | $27.38 | $490,549 | 1,399,004 (Direct) |
View |
| 2022-10-10 Sale |
2022-10-11 1:12 pm |
Vir Biotechnology Inc. | VIR | SATO VICKI L Director |
17,915 | $20.67 | $370,278 | 1,416,919 (Direct) |
View |
| 2022-09-08 Sale |
2022-09-09 1:47 pm |
Vir Biotechnology Inc. | VIR | SATO VICKI L Director |
17,915 | $21.9 | $392,335 | 1,434,834 (Direct) |
View |
| 2022-08-15 Sale |
2022-08-17 4:53 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
130,364 | $27.97 | $3,645,758 | 22,086,280 (Indirect) |
View |
| 2022-08-08 Sale |
2022-08-09 6:26 pm |
Vir Biotechnology Inc. | VIR | SATO VICKI L Director |
17,915 | $30.29 | $542,685 | 1,452,749 (Direct) |
View |
| 2022-07-20 Sale |
2022-07-21 4:10 pm |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
5,000 | $30 | $150,000 | 182,982 (Direct) |
View |
| 2022-07-11 Sale |
2022-07-13 4:05 pm |
Vir Biotechnology Inc. | VIR | Ramasastry Saira Director |
5,000 | $30 | $150,000 | 50,869 (Direct) |
View |
| 2022-07-08 Sale |
2022-07-12 4:46 pm |
Vir Biotechnology Inc. | VIR | SATO VICKI L Director |
17,915 | $29.06 | $520,694 | 1,470,664 (Direct) |
View |
| 2022-06-21 Sale |
2022-06-22 5:40 pm |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
4,991 | $24.89 | $124,209 | 144,000 (Direct) |
View |
| 2022-06-08 Sale |
2022-06-09 4:53 pm |
Vir Biotechnology Inc. | VIR | SATO VICKI L Director |
17,915 | $25.84 | $462,976 | 1,488,579 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-09-02 Other |
2022-09-07 8:30 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner |
1,058,333 | $0 | 1,662,347 (Indirect) |
View |
| 2022-09-02 Other |
2022-09-07 8:29 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner |
1,035,018 | $0 | 1,126,748 (Indirect) |
View |
| 2022-08-30 Other |
2022-09-01 5:22 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner |
1,058,346 | $0 | 1,604,027 (Indirect) |
View |
| 2022-08-30 Other |
2022-09-01 5:20 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner |
1,035,006 | $0 | 1,117,864 (Indirect) |
View |
| 2022-08-24 Other |
2022-08-26 5:15 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner |
1,058,346 | $0 | 1,545,681 (Indirect) |
View |
| 2022-08-24 Other |
2022-08-26 5:12 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner |
1,035,006 | $0 | 1,109,010 (Indirect) |
View |
| 2022-08-18 Other |
2022-08-22 5:15 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner |
529,173 | $0 | 958,162 (Indirect) |
View |
| 2022-08-18 Other |
2022-08-22 5:14 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner |
517,503 | $0 | 582,653 (Indirect) |
View |
| 2022-08-12 Other |
2022-08-16 9:05 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner |
1,587,519 | $0 | 1,987,335 (Indirect) |
View |
| 2022-08-12 Other |
2022-08-16 9:04 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner |
1,552,509 | $0 | 1,613,232 (Indirect) |
View |
| 2022-08-09 Exercise |
2022-08-10 4:50 pm |
N/A 2028-01-26 |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
78,093 | $0 | 528,244 (Direct) |
View |
| 2022-08-09 Exercise |
2022-08-10 4:50 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
7,916 | $10.39 | 528,244 (Direct) |
View |
| 2022-08-09 Exercise |
2022-08-10 4:50 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Virgin Herbert EVP, Research & CSO |
70,177 | $1.53 | 528,244 (Direct) |
View |
| 2022-07-20 Exercise |
2022-07-21 4:10 pm |
N/A 2028-07-19 |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
5,000 | $0 | 182,982 (Direct) |
View |
| 2022-07-20 Option Award |
2022-07-21 4:10 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
5,000 | $1.575 | 182,982 (Direct) |
View |
| 2022-07-11 Option Award |
2022-07-13 4:05 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Ramasastry Saira Director |
5,000 | $12.76 | 50,869 (Direct) |
View |
| 2022-07-11 Exercise |
2022-07-13 4:05 pm |
N/A 2029-12-09 |
Vir Biotechnology Inc. | VIR | Ramasastry Saira Director |
5,000 | $0 | 50,869 (Direct) |
View |
| 2022-04-15 Gift |
2022-06-22 5:40 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
7,777 | $0 | 144,000 (Direct) |
View |
| 2022-06-09 Other |
2022-06-13 4:17 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | MORE ROBERT J Director |
3,374 | $0 | 535,294 (Direct) |
View |
| 2022-06-08 Other |
2022-06-10 9:27 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner |
517,503 | $0 | 564,945 (Indirect) |
View |
| 2022-06-08 Other |
2022-06-10 9:24 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner |
529,173 | $0 | 841,470 (Indirect) |
View |
| 2022-06-02 Other |
2022-06-06 8:25 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner |
529,173 | $0 | 11,207,361 (Indirect) |
View |
| 2022-06-02 Other |
2022-06-06 8:24 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner |
517,502 | $0 | 10,955,581 (Indirect) |
View |
| 2022-05-23 Option Award |
2022-05-25 6:38 pm |
2023-05-23 2032-05-22 |
Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner |
19,215 | $0 | 19,183,424 (Direct) |
View |